Patents by Inventor Giulio Biagiotti

Giulio Biagiotti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia
    Patent number: 8415392
    Abstract: L-carnitine, acetyl L-carnitine and propionyl L-carnitine inner salts, or their pharmaceutically acceptable salts, are used in combination to treat oligoasthenoteratosperia including oligospermia, asthenospermia, and teratospermia.
    Type: Grant
    Filed: September 9, 2008
    Date of Patent: April 9, 2013
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite, S.p.A.
    Inventors: Giorgio Cavallini, Giulio Biagiotti, Aleardo Koverech, Francesca Sardelli
  • Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
    Patent number: 7956091
    Abstract: The use of propionyl L-carnitine in combination with acetyl L-carnitine, or one of their pharmaceutically acceptable salts, is disclosed for the preparation of a medicament, or of a nutritional supplement, for the prevention and/or treatment of the disorders of the male andropause caused by ageing or by chemical or surgical castration.
    Type: Grant
    Filed: November 20, 2003
    Date of Patent: June 7, 2011
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Aleardo Koverech, Giorgio Cavallini, Giulio Biagiotti
  • Carnitines for treating or preventing disorders caused by andropause
    Patent number: 7776913
    Abstract: L-carnitine, propionyl L-carnitine and/or acetyl L-carnitine are used to prevent or treat disorders of male andropause caused by ageing or by chemical or surgical castration.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: August 17, 2010
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Aleardo Koverech, Giulio Biagiotti, Giorgio Cavallini
  • Combined use of L-carnitine, acetyle L-carnitine and propionyl L-carnitine for the treatment of oligoasthenoteratospermia
    Publication number: 20090012169
    Abstract: L-carnitine, acetyl L-carnitine and propionyl L-carnitine inner salts, or their pharmaceutically acceptable salts, are used in combination to treat oligoasthenoteratosperia including oligospermia, asthenospermia, and teratospermia.
    Type: Application
    Filed: September 9, 2008
    Publication date: January 8, 2009
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Giorgio Cavallini, Giulio Biagiotti, Aleardo Koverech, Francesca Sardelli
  • Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
    Publication number: 20080287539
    Abstract: L-carnitine, propionyl L-carnitine and/or acetyl L-carnitine are used to prevent or treat disorders of male andropause caused by ageing or by chemical or surgical castration.
    Type: Application
    Filed: March 14, 2008
    Publication date: November 20, 2008
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.,
    Inventors: Aleardo Koverech, Giulio Biagiotti, Giorgio Cavallini
  • Combined use of l-carnitine, acetyl l-carnitine and propionyl l-carnitine for the treatment of oligoasthenoteratospermia
    Publication number: 20050107470
    Abstract: The use is described of L-carnitine and propionyl L-carnitine, or of one of their pharmaceutically acceptable salts for the preparation of a medicine for the treatment of oglioasthenoteratospermia of any origin.
    Type: Application
    Filed: April 8, 2003
    Publication date: May 19, 2005
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A
    Inventors: Giorgio Cavillini, Giulio Biagiotti, Aleardo Koverech, Francesca Sardelli
  • Use of propionyl-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
    Publication number: 20050038044
    Abstract: The invention described herein relates to the use of propionyl L-carnitine or one of its pharmaceutically acceptable salts for the preparation of a medicine useful for the treatment of La Peyronie's disease in its various stages, particularly at the advanced stage and in forms resistant to conventional therapies. The medicine is suitable for oral, intramuscular, intravenous, and intraplaque administration. The invention described herein also relates to a combination of an active ingredient in the treatment of La Peyronie's disease, particularly verapamil, and propionyl L-carnitine or one of its pharmaceutically acceptable salts. Propionyl L-carnitine has proved to be more effective than the known active ingredients, also in intractable forms, and presents a lower incidence of side effects.
    Type: Application
    Filed: November 26, 2002
    Publication date: February 17, 2005
    Inventors: Aleardo Koverech, Giorgio Cavallini, Giulio Biagiotti